Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) (LIPOMYX)
Hypofractionated 5x5 Gy Radiotherapy With Prolonged Gap Before Surgery in Preoperative Treatment of Patients With Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall
Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology
A PHASE2 clinical study on Myxoid Liposarcoma, this trial is ongoing. The trial is conducted by Maria Sklodowska-Curie National Research Institute of Oncology and has accumulated 7 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Mar 2024 — Jul 2024 [monthly]
Unknown Status PHASE2
Status: Active Not Recruiting → Unknown Status
-
Jan 2022 — Mar 2024 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE2
▶ Show 2 earlier versions
-
Jul 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Feb 2019 — Jul 2019 [monthly]
Active Not Recruiting PHASE2
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Maria Sklodowska-Curie National Research Institute of Oncology
For direct contact, visit the study record on ClinicalTrials.gov .